4EM9 | Human PPAR gamma in complex with nonanoic acids | date | 2012-04-11 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Liberato, M.V., Nascimento, A.S., Polikarpov, I. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.10 | ||||||||||||
ligand | GOL, KNA, TCE | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) gamma activators and pan-PPAR partial agonists., Liberato MV, Nascimento AS, Ayers SD, Lin JZ, Cvoro A, Silveira RL, Martinez L, Souza PC, Saidemberg D, Deng T, Amato AA, Togashi M, Hsueh WA, Phillips K, Palma MS, Neves FA, Skaf MS, Webb P, Polikarpov I, PLoS One. 2012;7(5):e36297. doi: 10.1371/journal.pone.0036297. Epub 2012 May 23. PMID:22649490 |
Data retrieval |
View 4EM9 in 3D |
Visual 3D analysis of 4EM9 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4EM9 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |